- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02564822
Effects of the Visual Stimulation on the Motor and Visual Cortex in Migraneurs With and Without Aura
August 22, 2018 updated by: Kátia Monte-Silva, Universidade Federal de Pernambuco
The aim of this study is to investigate the motor and visual cortex excitability in response to visual stimulation of migraineurs with and without aura compared to healthy individuals.
For this purpose, electrical cortical activity of migraineurs will be compared to healthy volunteers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A cross sectional study to compare the best approach to migraineurs evaluation.
For this, healthy individuals, after reading and signing the free and informed consent will be submitted to a single session to obtain the normal neurophysiological endpoints and thus compare with those obtained in individuals with migraineurs volunteers.
All volunteers (healthy and migraineurs) will be submitted to a neurophysiological evaluation through transcranial magnetic stimulation (TMS) and electroencephalography (EEG).
A visual stimulation will be delivered during the assessment of habituation through visual evoked potential volunteers (VEP-habituation) and the following measures will be evaluated before and after visual stimulation: (i) Motor Evoked Potentials (MEP); (ii) Motor Threshold (MT); (iii) Short Interval Cortical Inhibition (SICI); (iv) Intracortical Facilitation (lCF) and (v) Phosphene Threshold (PT).
Study Type
Observational
Enrollment (Actual)
59
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
PE
-
Recife, PE, Brazil, 50670-901
- Laboratório de Neurociência Aplicada (LANA)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients and healthy volunteers will be recruited via advertisements on the university. Patients should have migraine diagnosis according to the International Classification of Headache Disorders (ICHD-III) criteria and clinical diagnosis by a neurologist.
For control subjects the individuals should not have migraine diagnosis assessed according to IHCD-III criteria.
Description
Inclusion Criteria:
- Ages: 18-55 years
- Gender: Both
- Prior headache report
Exclusion Criteria:
- Pregnant women;
- Pacemaker;
- History of seizures;
- Metallic implants in the head;
- Patients with clinical evidence of brain injuries;
- Chronic pain associated to others diseases;
- Use of neuroleptic medications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Migraneurs - Visual stimulation
Patients will be recruited via advertisements on the university.
Patients should have migraine diagnosis according to the International Classification of Headache Disorders (ICHD-III) criteria and clinical diagnosis by a neurologist.
|
volunteers will be invited to sit in a comfortable chair, in a calm and dark room, at 90 cm of distance from computer screen.
It will be asked to fix his right eye visual field on a red point at the center of the screen (the left one will be blindfolded).
Visual stimuli will be a black and White grid pattern, alternating at a frequency of 3.1 Hz.
|
|
Control - Visual stimulation
Healthy volunteers will be recruited via advertisements on the university.
For control subjects the individuals should not have migraine diagnosis assessed according to IHCD-III criteria.
|
volunteers will be invited to sit in a comfortable chair, in a calm and dark room, at 90 cm of distance from computer screen.
It will be asked to fix his right eye visual field on a red point at the center of the screen (the left one will be blindfolded).
Visual stimuli will be a black and White grid pattern, alternating at a frequency of 3.1 Hz.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes on motor evoked potentials
Time Frame: one day (Before and after visual stimulation)
|
to measure MEP, the intensity of the magnetic stimulator will be adjusted to 120% of rest motor threshold and 10 stimuli will be registered.
For evaluation volunteers will be instructed to sit in a chair and get into a comfortable position.
Initially, single-pulse TMS will be administered over the motor cortex to determine the cortical representation area of the first dorsal interosseous muscle (FDI).
For all evaluations the same figure-eight coil is used, in order to avoid measurement bias.
Amplitude means of evoked potentials will determine the MEP.
|
one day (Before and after visual stimulation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes on short interval intracortical inhibition
Time Frame: one day (Before and after visual stimulation)
|
to evaluate this variable, subthreshold conditioning stimuli (80% of RMT) and suprathreshold test stimuli (120% of RMT) will be delivered at an inter stimulus intervals (ISI) of 2 milliseconds, to determine the short interval cortical inhibition (SICI).
Ten stimuli will be applied in each condition (unconditioned pulse and pairs of stimuli with ISI of 2 milliseconds).
The order of stimulus delivered will be pseudorandomized and SICI will be expressed as a percentage of a conditioned stimuli in regarding an unconditioned stimuli.
|
one day (Before and after visual stimulation)
|
|
Changes on intracortical facilitation
Time Frame: one day (Before and after visual stimulation)
|
to evaluate intracortical facilitation (ICF), subthreshold conditioning stimuli (80% of RMT) and suprathreshold test stimuli (120% of RMT) will be delivered at an inter stimulus intervals (ISI) of 10 milliseconds.
Ten stimulus will be applied in each condition (unconditioned pulse and pairs of stimuli with ISI of 10 milliseconds).
The order of stimuli delivered will be pseudorandomized and ICF will be expressed as a percentage of a conditioned stimuli in regarding an unconditioned stimuli.
|
one day (Before and after visual stimulation)
|
|
Changes from phosphene threshold
Time Frame: one day (Before and after visual stimulation)
|
a 10-cm circular coil was used that has giving a peak magnetic field strength of 2 tesla.
Subjects were asked to wear a blindfold, sit comfortably in a chair and to close their eyes to diminish ambient light.In sagittal line, three points were scored: 2, 3 and 4 cm above the inion.
The single pulse TMS was applied to one of the points scored and the subject was asked to report the presence or absence of a phosphene immediately after stimulation.
The stimulation was repeated ten times at each intensity with a maximum frequency of 0.2 Hz, stimulation was initially applied to 60% of the maximum intensity of the stimulator.
The intensity of stimulation was changed into blocks of 5% to minimum intensity that the subject can perceive the phosphene certainly, five times ten, then this value was set as the PT.
|
one day (Before and after visual stimulation)
|
|
Habituation of Visual Evoked Potentials evaluated by Electroencephalography
Time Frame: one day (during visual stimulation)
|
volunteers will be invited to sit in a comfortable chair, in a calm and dark room, at 90 cm of distance from computer screen.
It will be asked to fix his right eye visual field on a red point at the center of the screen (the left one will be blindfolded).
Visual stimuli will be a black and White grid pattern, alternating at a frequency of 3.1 Hz.
Electrodes used to record data will be localized on Oz and Fz points according International 10-20 system.
During the test, 600 cortical answers will be recorded.
Data will be collected and recorded in a personal computer, and after, converted to the ".txt" format to futures analysis with MATLAB.
|
one day (during visual stimulation)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2015
Primary Completion (ACTUAL)
June 1, 2016
Study Completion (ACTUAL)
August 1, 2016
Study Registration Dates
First Submitted
September 22, 2015
First Submitted That Met QC Criteria
September 29, 2015
First Posted (ESTIMATE)
October 1, 2015
Study Record Updates
Last Update Posted (ACTUAL)
August 24, 2018
Last Update Submitted That Met QC Criteria
August 22, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VisualStimulation_Migraine
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine Disorders
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingMigraine | Migraine Headache | Migraine Without Aura | Migraine with Aura | Chronic Migraine, Headache | Episodic Migraine | Chronic Migraine Headache | Headache (Migraine) | Episodic Migraine HeadacheSpain
-
Brigham and Women's HospitalNot yet recruitingMigraine Disorders | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Austrian Migraine Registry CollaborationMedical University of Vienna; Medical University Innsbruck; Austrian Headache...RecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineAustria
-
Harvard University Faculty of MedicineBrigham and Women's Hospital; Palmer Center for Chiropractic Research (PCCR)CompletedMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura | Migraine, ClassicUnited States
-
CoolTech LLCTerminatedMigraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Notre-Dame Hospital, Montreal, Quebec, CanadaAllerganCompletedChronic Migraine | Migraine Without Aura | Migraine With AuraCanada
-
Glostrup University Hospital, CopenhagenUnknownChronic Migraine | Migraine Without Aura | Migraine With AuraDenmark
-
Vastra Gotaland RegionNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...RecruitingMigraine Without Aura | Migraine With AuraChina
-
Assiut UniversityNot yet recruitingMigraine Without Aura | Migraine With Aura
Clinical Trials on Visual Stimulation
-
National Council of Scientific and Technical Research...Completed
-
Hospices Civils de LyonCompleted
-
Fondazione David Chiossone - Impresa SocialeIRCCS AOU San Martino, Genova, ItalyNot yet recruitingHemianopia | Visual Field Defect Following Cerebrovascular Accident
-
Selcuk UniversityCompletedPreterm Labor | Cesarean Delivery Affecting FetusTurkey
-
University of RochesterNational Eye Institute (NEI)Completed
-
Technical University of MunichRecruitingSchizoaffective Disorder | Schizophrenia Disorders | Negative Symptoms in SchizophreniaGermany
-
University Hospital, GrenobleRecruitingPhysiological Reactivity to CuesFrance
-
Dandelion ScienceNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
University of FloridaNot yet recruitingHealthy Subjects | Subjective Cognitive Decline (SCD)United States
-
Region SkaneLund UniversityCompletedNeurodevelopmental Disorders | Attention Deficit Hyperactivity DisorderSweden